Available resources and guidance
Philips has released a report with updated information on testing results and third party confirmed conclusions to date on results and findings from testing PE‐PUR foam used in recalled devices for volatile organic compounds, particulate matter, and other testing.
Philips has shared new details on how the company is prioritizing remediation of those patients potentially at higher risk.
A new webpage from Philips gives patients an overview of the recall process and enables them to check the status of their order.
Philips has updated and expanded its webpage with numerous resources relating to the recall.
The US Food and Drug Administration has issued recommendations for patients, health care providers, and facilities.
Get the latest information from the FDA on a new recall of certain Trilogy Evo ventilators that were not included in the June 2021 recall.
Patients with affected devices should register their devices with Philips.
The American Academy of Sleep Medicine (AASM) offers guidance for clinicians, such as sample patient communications, clinical assessment tools, webinar recordings, and more.
These societies have provided guidance to physicians and medical device distributors with regard to the recent recall notice.